BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6324423)

  • 1. Anti-D prozone and membrane sulfhydryl modification.
    Jameson JT; Kleeman JE; Masouredis SP; Victoria EJ
    Transfusion; 1984; 24(2):130-5. PubMed ID: 6324423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of an antigen on the inner surface of Rh negative erythrocytes which binds anti-D IgG.
    Evans JP; Brown PJ; Sinor LT; Tilzer LL; Beck M; Plapp FV
    Mol Immunol; 1983 May; 20(5):529-36. PubMed ID: 6308430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mode of attenuation of erythrocyte membrane Rh0(D) antigen activity by 5,5'-dithiobis-(2-nitrobenzoic acid) and protection against loss of activity by bound anti-Rh0(D) antibody.
    Green FA
    Mol Immunol; 1983 Jul; 20(7):769-75. PubMed ID: 6412073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rh antigen immunoreactivity after histidine modification.
    Victoria EJ; Branks MJ; Masouredis SP
    Mol Immunol; 1986 Oct; 23(10):1039-44. PubMed ID: 3099174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of enzyme-treated red blood cell surface and haemagglutination using a theory of soft-particle electrophoresis.
    Hyono A; Mazda T; Okazaki H; Tadokoro K; Ohshima H
    Vox Sang; 2008 Aug; 95(2):131-6. PubMed ID: 18510578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The phospholipid requirement for Rho(D) antigen activity: mode of inactivation by phospholipases and of protection by anti-Rh0(D) antibody.
    Green FA; Hui HL; Green LA; Heubusch P; Pudlak W
    Mol Immunol; 1984 Jun; 21(6):433-8. PubMed ID: 6431264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of the membrane skeleton on the immunologic reactivity of the human red cell Rho(D) antigen.
    Paradis G; Bazin R; Lemieux R
    J Immunol; 1986 Jul; 137(1):240-4. PubMed ID: 3086450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of membrane cholesterol depletion on the immunoreactivity of the D antigen and IgG anti-D.
    Victoria EJ; Kleeman JE; Sudora EJ; Masouredis SP
    Immunol Invest; 1986 Jun; 15(4):393-404. PubMed ID: 3093376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential binding of IgG anti-D and IgG autoantibodies to reticulocytes and red blood cells.
    Gray LS; Kleeman JE; Masouredis SP
    Br J Haematol; 1983 Oct; 55(2):335-45. PubMed ID: 6311240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical compounds that target thiol-disulfide groups on mononuclear phagocytes inhibit immune mediated phagocytosis of red blood cells.
    Rampersad GC; Suck G; Sakac D; Fahim S; Foo A; Denomme GA; Langler RF; Branch DR
    Transfusion; 2005 Mar; 45(3):384-93. PubMed ID: 15752156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of an anti-D monoclonal antibody using unconventional techniques].
    Almará A; Biondi C; García Rosasco M; Racca A; Morisoli L; Valverde J
    Sangre (Barc); 1993 Feb; 38(1):69. PubMed ID: 8385809
    [No Abstract]   [Full Text] [Related]  

  • 12. Heterogeneity of IgG1 monoclonal anti-Rh(D): an investigation using ADCC and macrophage binding assays.
    Armstrong SS; Wiener E; Garner SF; Urbaniak SJ; Contreras M
    Br J Haematol; 1987 Jun; 66(2):257-62. PubMed ID: 3038161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Rho(D) polypeptides with the membrane skeleton in Rho(D)-positive human red cells.
    Gahmberg CG; Karhi KK
    J Immunol; 1984 Jul; 133(1):334-7. PubMed ID: 6427341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of passively administered anti-Rh to prevent secondary Rh responses.
    de Silva M; Contreras M; Mollison PL
    Vox Sang; 1985; 48(3):178-80. PubMed ID: 2984846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteolysis of band 3 is enhanced by anti-Rho(D) binding to the red cell membrane.
    Victoria EJ; Kleeman JE; Masouredis SP
    Biochem Biophys Res Commun; 1984 Oct; 124(2):437-42. PubMed ID: 6437402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of antigen mobility in anti-Rh0(D)-induced agglutination.
    Victoria EJ; Muchmore EA; Sudora EJ; Masouredis SP
    J Clin Invest; 1975 Aug; 56(2):292-301. PubMed ID: 807597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Rho(D) IgG binds to band 3 glycoprotein of the human erythrocyte membrane.
    Victoria EJ; Mahan LC; Masouredis SP
    Proc Natl Acad Sci U S A; 1981 May; 78(5):2898-902. PubMed ID: 6789325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient anti-D in an Rh-positive patient with congenital dyserythropoietic anemia type II.
    Krikler SH; Ferguson DJ; Akabutu JJ; Lomas CG
    Transfusion; 1984; 24(2):169-70. PubMed ID: 6324425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive antiglobulin test in association with sulindac: involvement of the Rh factor.
    DeCoteau J; Reis MD; Pinkerton PH; Ward J; Coovadia AS
    Vox Sang; 1993; 64(3):179-83. PubMed ID: 8484252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antiglobulin reaction with native and enzyme-modified red cells.
    Rearden A; Masouredis SP
    Transfusion; 1980; 20(4):377-83. PubMed ID: 6773190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.